Bender Jeremy

Bender Jeremy is listed in filings as CHIEF EXECUTIVE OFFICER at Day One Biopharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Apr 23, 2026, including sale activity. Recent filings connect the profile to Day One Biopharmaceuticals, Inc. (DAWN) and Mereo BioPharma Group plc (MREO). The current snapshot covers public activity from Jun 17, 2024 to Apr 23, 2026. Reported amounts are shown as $4.0M to $81. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.